✦ LIBER ✦

Personalized cost-effectiveness of boceprevir-based triple therapy for untreated patients with genotype 1 chronic hepatitis C

✍ Scribed by Petta, S.; Cabibbo, G.; Enea, M.; Macaluso, F.S.; Plaia, A.; Bruno, R.; Gasbarrini, A.; Orlando, E.; Craxì, A.; Cammà, C.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Personalized cost-effectiveness of bocep

✍ Petta, Salvatore; Cabibbo, Giuseppe; Enea, Marco; Macaluso, Fabio Salvatore; Pla 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 998 KB

Cost-effectiveness of sofosbuvir-based t

✍ Petta, S.; Cabibbo, G.; Enea, M.; Macaluso, F.S.; Plaia, A.; Bruno, R.; Gasbarri 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 58 KB

Cost-effectiveness of sofosbuvir-based t

✍ Petta, Salvatore; Cabibbo, Giuseppe; Enea, Marco; Macaluso, Fabio Salvatore; Pla 📂 Article 📅 2014 🏛 John Wiley and Sons 🌐 English ⚖ 868 KB

Boceprevir for previously untreated pati

✍ Shannon Allen Ferrante, Jagpreet Chhatwal, Clifford A Brass… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 303 KB

Cost-Effectiveness Of Boceprevir Therapy

✍ Mernagh, P.; Feng, J.; Del Cuore, M 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Cost-effectiveness of boceprevir or tela

✍ Cammà, Calogero; Petta, Salvatore; Cabibbo, Giuseppe; Ruggeri, Matteo; Enea, Mar 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 277 KB